Bvf Inc Molecular Partners Ag Call Options Transaction History
Bvf Inc
- $3.27 Billion
- Q2 2024
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|
Others Institutions Holding MOLN
# of Institutions
9Shares Held
860KCall Options Held
0Put Options Held
0-
Suvretta Capital Management, LLC New York, NY400KShares$2.2 Million0.12% of portfolio
-
Old Mission Capital LLC10.4KShares$57,1110.0% of portfolio
-
Ubs Group Ag3.46KShares$19,0700.0% of portfolio
-
Tang Capital Management LLC San Diego, CA2.5KShares$13,7750.0% of portfolio
-
Morgan Stanley New York, NY367Shares$2,0220.0% of portfolio
About MOLECULAR PARTNERS AG
- Ticker MOLN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 32,514,000
- Market Cap $179M
- Description
- Molecular Partners AG operates as a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic proteins. Its products candidates include Abicipar, a DARPin therapeutic candidate, which is in Phase III clinical trials for the treatment of neovascular wet age-related macular degeneration, ...